Bill Sponsors: NJ S2143 | 2022-2023 | Regular Session

Bill Title: Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2022-03-07 - Introduced in the Senate, Referred to Senate Commerce Committee [S2143 Detail]

Text: Latest bill text (Introduced) [HTML]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Senator Fred Madden [D]PrimarySponsored BillsSD-004FollowTheMoneyBallotpediaVoteSmart

Social Comments on NJ S2143

feedback